Company Overview
Snapshot
Founded in January 2018, Scentech Medical operates with 1–10 employees, focusing on breath diagnostic technology. The company is currently in the Pre-Funding stage. In August 2021, Scentech Medical signed a cooperation agreement with the Biological Institute, signaling a strategic move for its technology development.
Business overview
Scentech Medical develops non-invasive, real-time screening solutions for infectious diseases, providing instant results through a simple breath test. The company's core technology detects unique metabolic processes associated with pathogens, creating a singular metabolic fingerprint for each. This enables Scentech Medical's Rapid Scent Test to identify various pathogens, even in early, asymptomatic stages of infection. The company operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Medical Devices, targeting healthcare providers with its diagnostic solutions.
Strategic signal
In February 2022, Scentech Medical underwent a leadership change, bringing in the former director of the Biological Institute to move the company forward. This strategic personnel shift suggests an effort to strengthen leadership and potentially accelerate development or market entry, particularly following earlier reports of the company's technology not being mature enough for investment.
Log in to access full profile ›Company Intelligence Q&A
- What is Scentech Medical's primary focus?
- Scentech Medical specializes in developing non-invasive, real-time breath diagnostic technology for infectious diseases, aiming to provide instant results by identifying unique metabolic fingerprints associated with pathogens.
- When was Scentech Medical founded?
- Scentech Medical was founded in January 2018.
- What significant partnership did Scentech Medical establish?
- In August 2021, Scentech Medical signed a cooperation agreement with the Biological Institute, indicating a strategic collaboration for its technology development.
- What was a key leadership development for Scentech Medical?
- In February 2022, Scentech Medical brought in the former director of the Biological Institute to its leadership team, a move aimed at strengthening the company's direction and potentially addressing prior concerns about its maturity for investment.
- What is Scentech Medical's current product stage?
- Scentech Medical's product, the Rapid Scent Test, is currently in the Clinical Trial stage.